本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Jasper Therapeutics

5.26
-0.1500-2.77%
盘后5.260.00000.00%18:44 EDT
成交量:17.22万
成交额:91.94万
市值:7,901.64万
市盈率:-1.00
高:5.51
开:5.41
低:5.23
收:5.41
数据加载中...
2024/06/07

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/06/07

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/06/07

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/06/07

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/05/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/03/27

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/03/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/05

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/05

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/04

重要事件披露

Form 8-K - Current report
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/12

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/02/09

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/02/06

重要事件披露

Form 8-K - Current report
2024/02/05

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/02

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/04

重要事件披露

Form 8-K - Current report